MedTrace Logo

Effects of Gait Rehabilitation With Dual Task in Patients With Parkinson's Disease

NCT04038866 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-12-10

No results posted yet for this study

Summary

In functional environments, dual-tasks (DT) are common and require a correct motor and cognitive performance to be carried out successfully. In people with neurodegenerative diseases such as Parkinson's disease (PD), to walk with a secondary task affects gait. The inclusion of DT to the assessment and physical rehabilitation of patients allows to simulate day-to-day contexts in a controlled and safe environment and consequently, extrapolate more easily the advances of rehabilitation to daily life.

This project studied the effects of a gait rehabilitation program with dual tasks (DUALGAIT) in patients with Parkinson's disease and compared the results with a control active group of patients who performed a general physical rehabilitation program (without dual-task and only motor exercise practice).

The investigator's hypothesis is that gait training under dual conditions has a greater effect than traditional motor physiotherapy programs on the biomechanics of parkinsonian gait.

The present study is a randomized controlled clinical trial, with evaluators blind to the allocation of participants in the different groups.

Conditions

  • Parkinson Disease

Interventions

OTHER

rehabilitation gait with dual task

OTHER

rehabilitation gait without dual task

Sponsors & Collaborators

  • Asociación Parkinson Valencia

    collaborator OTHER

  • Hospital Universitario La Fe

    collaborator OTHER

  • University of Valencia

    lead OTHER

Principal Investigators

  • Constanza I San Martín Valenzuela, PhD · Faculty of Medicine, University of Valencia

  • Pilar Serra Añó, PhD · Faculty of Physiotherapy, University of Valencia

  • José Manuel Tomás Miguel, PhD · Faculty of Psychology, University of Valencia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-06-14
Primary Completion
2016-06-30
Completion
2016-06-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04038866 on ClinicalTrials.gov